Join Richard Auchus, MD, PhD, for this virtual program exploring classic congenital adrenal hyperplasia (CAH) outside of 21-hydroxylase deficiency (21-OHD). This program will examine how the distinct genetic defects underlying non-21-OHD forms of classic CAH result in different biochemical profiles and clinical phenotypes that can influence disease severity, long-term outcomes, and management approaches.
Attendees will gain practical insights into the differential diagnosis of the various types of non‑21-OHD classic CAH, the laboratory and genetic testing used to distinguish them, and individualized monitoring and treatment strategies, including reproductive strategies in women with these disorders.
